# Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

> **NCT05379907** · — · WITHDRAWN · sponsor: **Inova Health Care Services**

## Conditions studied

- Pancreatic Cancer

## Interventions

- **OTHER:** SIGNATERA™ ctDNA testing

## Key facts

- **NCT ID:** NCT05379907
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08-23
- **Primary completion:** 2023-08-23
- **Final completion:** 2023-08-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Determined that the tumor analysis could not be performed in accordance with the protocol.
- **Last updated:** 2023-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05379907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05379907, "Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05379907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*